MET: a promising anticancer therapeutic target

S Peters, AA Adjei - Nature reviews Clinical oncology, 2012‏ - nature.com
The MET pathway is dysregulated in many human cancers and promotes tumour growth,
invasion and dissemination. Abnormalities in MET signalling have been reported to …

Lymphoma dissemination: the other face of lymphocyte homing

ST Pals, DJJ de Gorter… - Blood, The Journal of the …, 2007‏ - ashpublications.org
The orchestration of systemic immune responses is critically dependent on coordinated
lymphocyte migration and recirculation. This “homing” guides lymphocytes to the …

A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling

Y Abe, M Sakata-Yanagimoto, M Fujisawa… - Nature cell …, 2022‏ - nature.com
The activities of non-haematopoietic cells (NHCs), including mesenchymal stromal cells and
endothelial cells, in lymphomas are reported to underlie lymphomagenesis. However, our …

Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma …

P Amé-Thomas, H Maby-El Hajjami, C Monvoisin… - Blood, 2007‏ - ashpublications.org
Accumulating evidence indicates that the cellular microenvironment plays a key role in
follicular lymphoma (FL) pathogenesis, both within tumor lymph nodes (LNs) and in …

Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases

GM Coudriet, J He, M Trucco, WM Mars, JD Piganelli - PloS one, 2010‏ - journals.plos.org
The generation of the pro-inflammatory cytokines IL-6, TNF-α, and IL-1β fuel the acute phase
response (APR). To maintain body homeostasis, the increase of inflammatory proteins is …

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

AP Bhatt, PM Bhende, SH Sin, D Roy… - Blood, The Journal …, 2010‏ - ashpublications.org
Primary effusion lymphoma (PEL) constitutes a subset of non-Hodgkin lymphoma whose
incidence is highly increased in the context of HIV infection. Kaposi sarcoma–associated …

[HTML][HTML] New insights into diffuse large B-cell lymphoma pathobiology

AG Solimando, T Annese, R Tamma, G Ingravallo… - Cancers, 2020‏ - mdpi.com
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL),
accounting for about 40% of all cases of NHL. Analysis of the tumor microenvironment is an …

[HTML][HTML] Mechanisms of hepatocyte growth factor activation in cancer tissues

M Kawaguchi, H Kataoka - Cancers, 2014‏ - mdpi.com
Hepatocyte growth factor/scatter factor (HGF/SF) plays critical roles in cancer progression
through its specific receptor, MET. HGF/SF is usually synthesized and secreted as an …

IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis

PY Chu, WC Huang, SL Tung, CY Tsai, CJ Chen… - Cell & bioscience, 2022‏ - Springer
Abstract Background Targeting the HGF/MET signaling pathway has been a viable
therapeutic strategy for various cancer types due to hyperactivation of HGF/MET axis occurs …

FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells

M van Keimpema, LJ Grüneberg… - Blood, The Journal …, 2014‏ - ashpublications.org
The forkhead transcription factor FOXP1 is involved in B-cell development and function and
is generally regarded as an oncogene in activated B-cell–like subtype of diffuse large B-cell …